TECOGEN INC/WALTHAM MA (TGEN) Stock Fundamental Analysis
USA - NYSEARCA:TGEN - US87876P2011 - Common Stock
8.27 USD
-0.39 (-4.5%)
8.58 USD
+0.31 (+3.75%)
Overall TGEN gets a fundamental rating of 3 out of 10. We evaluated TGEN against 41 industry peers in the Building Products industry. TGEN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TGEN is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TGEN has reported negative net income.
TGEN had a positive operating cash flow in the past year.
TGEN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TGEN reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -15.31%, TGEN is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
With a Return On Equity value of -46.53%, TGEN is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.31% | ||
| ROE | -46.53% | ||
| ROIC | N/A |
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TGEN has a better Gross Margin (43.64%) than 82.93% of its industry peers.
In the last couple of years the Gross Margin of TGEN has grown nicely.
The Profit Margin and Operating Margin are not available for TGEN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
2. Health
2.1 Basic Checks
TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
TGEN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TGEN has been increased compared to 5 years ago.
The debt/assets ratio for TGEN is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.72 indicates that TGEN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.72, TGEN is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
TGEN has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.63, TGEN belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that TGEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, TGEN is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 5.72 |
ROIC/WACCN/A
WACC9.63%
2.3 Liquidity
TGEN has a Current Ratio of 1.32. This is a normal value and indicates that TGEN is financially healthy and should not expect problems in meeting its short term obligations.
TGEN's Current ratio of 1.32 is on the low side compared to the rest of the industry. TGEN is outperformed by 75.61% of its industry peers.
A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.74, TGEN is doing worse than 85.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The earnings per share for TGEN have decreased strongly by -220.48% in the last year.
Looking at the last year, TGEN shows a small growth in Revenue. The Revenue has grown by 2.46% in the last year.
The Revenue has been decreasing by -5.52% on average over the past years.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%54.33%
3.2 Future
Based on estimates for the next years, TGEN will show a very strong growth in Earnings Per Share. The EPS will grow by 38.30% on average per year.
TGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.20% yearly.
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TGEN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TGEN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
TGEN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. TGEN is more expensive than 70.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 79.43 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
TGEN's earnings are expected to decrease with -20.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
5. Dividend
5.1 Amount
TGEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
8.27
-0.39 (-4.5%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners15.06%
Inst Owner Change2.1%
Ins Owners23.08%
Ins Owner Change5.96%
Market Cap245.54M
Revenue(TTM)25.00M
Net Income(TTM)-4760300
Analysts82.86
Price Target15.3 (85.01%)
Short Float %6.78%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-189.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-49.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 10.86 | ||
| P/FCF | 79.43 | ||
| P/OCF | 60.47 | ||
| P/B | 24 | ||
| P/tB | 45.72 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY1.26%
OCF(TTM)0.14
OCFY1.65%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.31% | ||
| ROE | -46.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.64% | ||
| FCFM | 13.67% |
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 175.01% | ||
| Cap/Sales | 4.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 5.72 |
F-Score4
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-20.14%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%54.33%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.59%
EBIT Next 3Y70.17%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A
TECOGEN INC/WALTHAM MA / TGEN FAQ
What is the fundamental rating for TGEN stock?
ChartMill assigns a fundamental rating of 3 / 10 to TGEN.
Can you provide the valuation status for TECOGEN INC/WALTHAM MA?
ChartMill assigns a valuation rating of 0 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.
What is the profitability of TGEN stock?
TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.
How financially healthy is TECOGEN INC/WALTHAM MA?
The financial health rating of TECOGEN INC/WALTHAM MA (TGEN) is 5 / 10.
Can you provide the expected EPS growth for TGEN stock?
The Earnings per Share (EPS) of TECOGEN INC/WALTHAM MA (TGEN) is expected to decline by -53% in the next year.